UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045439
Receipt number R000051878
Scientific Title The effect of intensive care for diet and exercise for prevention of sarcopenia
Date of disclosure of the study information 2021/11/01
Last modified on 2024/03/13 11:53:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of intensive care for diet and exercise for prevention of sarcopenia

Acronym

Koshi Study 1

Scientific Title

The effect of intensive care for diet and exercise for prevention of sarcopenia

Scientific Title:Acronym

Koshi Study 1

Region

Japan


Condition

Condition

metabolic disease, sarcopenia

Classification by specialty

Medicine in general Endocrinology and Metabolism Geriatrics
Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Prevention of sarcopenia

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We evaluate lean body weight and fat mass by bioelectric impedance method in control group and high protein group.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

High protein intensive care every two months for two years

Interventions/Control_2

Standard intensive care every two months for two years

Interventions/Control_3

Standard care every six months for two years

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

HbA1c<6.5%, FB<126
SBP<140, DBP<90
40<HDL<96
LDL<160
TG<150
16<BMI<25
eGFR>60
65<Age<80

Key exclusion criteria

Person who
has cancer
has nutrition disorder
has severe disease
joins other clinical trial
can't understand this clinical study

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Eiichi
Middle name
Last name Araki

Organization

Kumamoto University

Division name

Center for metabolic regulation of healthy aging

Zip code

8608556

Address

Chuoku Honjyo1-1-1 , Kumamoto City, Kumamoto Prefecture Japan

TEL

0963737380

Email

fukudakazuki@kumamoto-u.ac.jp


Public contact

Name of contact person

1st name Kazuki
Middle name
Last name Fukuda

Organization

Kumamoto University

Division name

Center for metabolic regulation of healthy aging

Zip code

8608556

Address

Chuoku Honjyo1-1-1 , Kumamoto City, Kumamoto Prefecture Japan

TEL

0963737380

Homepage URL


Email

fukudakazuki@kumamoto-u.ac.jp


Sponsor or person

Institute

Center for metabolic regulation of healthy aging Kumamoto University

Institute

Department

Personal name



Funding Source

Organization

Center for metabolic regulation of healthy aging Kumamoto University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Center for metabolic regulation of healthy aging Kumamoto University

Address

Chuoku Honjyo1-1-1 , Kumamoto City, Kumamoto Prefecture Japan

Tel

0963737380

Email

fukudakazuki@kumamoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

91

Results

Intervention was finished as scheduled.

Results date posted

2024 Year 03 Month 13 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 07 Month 01 Day

Date of IRB

2021 Year 10 Month 27 Day

Anticipated trial start date

2021 Year 11 Month 01 Day

Last follow-up date

2023 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2024 Year 03 Month 30 Day


Other

Other related information



Management information

Registered date

2021 Year 09 Month 10 Day

Last modified on

2024 Year 03 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051878